Research References Peer-reviewed studies and database records underpinning the research described on this page
Supports the brain and nervous system
Ipamorelin selectivity characterisation: Landmark studies by Raun, Sehested Hansen, and colleagues at Novo Nordisk characterised Ipamorelin as the first GHRP with a selectivity profile resembling GH-releasing hormone producing robust GH release with essentially no elevation of cortisol, ACTH, or prolactin at doses producing maximal GH responses
A 2020 review in Diabetes Care noted that "the hypoglycaemic effect of IGF-1 has been exploited therapeutically in rare forms of insulin-receptor-defect syndromes, but the risk-benefit calculation differs fundamentally from use in euglycaemic individuals" [20]
If any guest has a medical condition, allergies or has had any medical treatments (including surgery) within the last six months please refer to the Medical Contraindications section of our Spa FAQS & Help page
This protocol ensures adequate intake